X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs DIVIS LABORATORIES - Comparison Results

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE DIVIS LABORATORIES SUVEN LIFE/
DIVIS LABORATORIES
 
P/E (TTM) x 17.1 35.4 48.3% View Chart
P/BV x 3.7 6.9 54.3% View Chart
Dividend Yield % 0.6 0.7 93.8%  

Financials

 SUVEN LIFE   DIVIS LABORATORIES
EQUITY SHARE DATA
    SUVEN LIFE
Mar-18
DIVIS LABORATORIES
Mar-18
SUVEN LIFE/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs2511,142 22.0%   
Low Rs155533 29.1%   
Sales per share (Unadj.) Rs49.1146.6 33.5%  
Earnings per share (Unadj.) Rs9.733.0 29.4%  
Cash flow per share (Unadj.) Rs11.438.4 29.7%  
Dividends per share (Unadj.) Rs1.5010.00 15.0%  
Dividend yield (eoy) %0.71.2 61.9%  
Book value per share (Unadj.) Rs60.3222.8 27.1%  
Shares outstanding (eoy) m127.28265.47 47.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.15.7 72.3%   
Avg P/E ratio x20.925.3 82.4%  
P/CF ratio (eoy) x17.821.8 81.7%  
Price / Book Value ratio x3.43.8 89.5%  
Dividend payout %15.430.3 51.0%   
Avg Mkt Cap Rs m25,825222,318 11.6%   
No. of employees `0001.110.8 10.0%   
Total wages/salary Rs m6134,561 13.4%   
Avg. sales/employee Rs Th5,832.63,616.0 161.3%   
Avg. wages/employee Rs Th571.5423.8 134.9%   
Avg. net profit/employee Rs Th1,153.8814.9 141.6%   
INCOME DATA
Net Sales Rs m6,25338,915 16.1%  
Other income Rs m2331,134 20.5%   
Total revenues Rs m6,48540,049 16.2%   
Gross profit Rs m1,98212,617 15.7%  
Depreciation Rs m2131,425 15.0%   
Interest Rs m4613 348.1%   
Profit before tax Rs m1,95512,313 15.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7183,543 20.3%   
Profit after tax Rs m1,2378,770 14.1%  
Gross profit margin %31.732.4 97.8%  
Effective tax rate %36.728.8 127.7%   
Net profit margin %19.822.5 87.8%  
BALANCE SHEET DATA
Current assets Rs m5,62245,351 12.4%   
Current liabilities Rs m1,1686,507 17.9%   
Net working cap to sales %71.299.8 71.4%  
Current ratio x4.87.0 69.1%  
Inventory Days Days81127 64.3%  
Debtors Days Days3695 37.8%  
Net fixed assets Rs m3,32521,160 15.7%   
Share capital Rs m127531 24.0%   
"Free" reserves Rs m7,54758,625 12.9%   
Net worth Rs m7,67459,156 13.0%   
Long term debt Rs m140-   
Total assets Rs m9,13567,832 13.5%  
Interest coverage x43.2926.8 4.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.6 119.3%   
Return on assets %14.012.9 108.5%  
Return on equity %16.114.8 108.7%  
Return on capital %26.020.8 124.9%  
Exports to sales %00-   
Imports to sales %021.8 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA8,485 0.0%   
Fx inflow Rs m5,06632,359 15.7%   
Fx outflow Rs m2,0019,042 22.1%   
Net fx Rs m3,06523,317 13.1%   
CASH FLOW
From Operations Rs m6997,759 9.0%  
From Investments Rs m-6-4,783 0.1%  
From Financial Activity Rs m-577-3,142 18.4%  
Net Cashflow Rs m116-166 -70.1%  

Share Holding

Indian Promoters % 63.4 52.0 121.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 11.8 -  
FIIs % 0.0 19.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 17.2 212.2%  
Shareholders   37,287 31,796 117.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   UNICHEM LAB  SUN PHARMA  PIRAMAL ENTERPRISES  GLENMARK PHARMA  AUROBINDO PHARMA  

Compare SUVEN LIFE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 300 Points Lower; Metal and IT Stocks Witness Selling(Closing)

Share markets in India witnessed most of the selling pressure during closing hours and ended their trading session on a negative note.

Related Views on News

DIVIS LABORATORIES Announces Quarterly Results (2QFY19); Net Profit Up 92.3% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 92.3% YoY). Sales on the other hand came in at Rs 13 bn (up 44.3% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

SUVEN LIFE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

Here's an analysis of the annual report of SUVEN LIFE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFE. Also includes updates on the valuation of SUVEN LIFE.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

5G Stocks: Cutting-Edge Technology that Could Make You Very Rich...(Profit Hunter)

Nov 12, 2018

A brand new technology and a stock that could soar with the upcoming 5G rollout.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Investing In Small Cap Funds? Read This Before You Invest(Outside View)

Nov 19, 2018

PersonalFN explains the care to take when investing in small-cap funds and the approach to follow.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Nov 20, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUVEN LIFE WITH

MARKET STATS